查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1871054

生物分解醫用塑膠市場：按產品類型、材料類型、加工技術、產品形式、應用和最終用戶分類－2025年至2032年全球預測

Biodegradable Medical Plastics Market by Product Type, Material Type, Processing Technology, Product Forms, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，可生物分解醫用塑膠市場將成長至 93.5 億美元，複合年成長率為 7.90%。

關鍵市場統計數據
基準年 2024 50.9億美元
預計年份：2025年 54.6億美元
預測年份 2032 93.5億美元
複合年成長率 (%) 7.90%

隨著可生物分解醫用塑膠在全球醫療保健系統中得到應用，臨床表現與永續性正日益融合。

醫療保健產業正處於關鍵的轉折點，環境保護與臨床療效必須兼顧。可生物分解的醫用塑膠已成為解決一次性醫療廢棄物日益增多、廢棄物處理難題以及聚合物基醫療設備碳足跡等問題的可行方案。聚合物化學、積層製造和加工技術以及可滅菌配方的進步，使設計人員和製造商能夠在不影響患者安全或符合監管規定的前提下，重新設計一次性產品和耐用零件。

材料多樣化、混合製造和不斷發展的監管採購框架如何共同重塑可生物分解醫用塑膠的未來應用路徑

一系列相互關聯的變革正在再形成可生物分解醫用塑膠的格局，這些變革正在重塑供應鏈、材料優先順序和製造模式。首先，材料多樣化正在推動能力的提升。聚乳酸和聚己內酯等替代材料不再是小眾產品，而是憑藉改進的配方和添加劑組合，提高了耐滅菌性和機械強度，成為更廣泛醫療應用領域的有力競爭者。同時，澱粉基複合材料和新型共聚物為需要快速生物分解的一次性耗材提供了經濟高效的選擇。

評估2025年美國關稅調整如何推動醫用聚合物供應鏈中的供應商多元化、近岸外包和垂直整合

美國近期推出的政策措施和2025年關稅調整對醫用聚合物及相關組件的國際供應鏈產生了顯著影響。部分進口樹脂和成品聚合物組件關稅的提高迫使製造商重新評估籌資策略、庫存管理政策和供應商多元化計畫。這些貿易政策的變化促使企業更加關注近岸外包和擴大國內生產能力，以確保關鍵醫療產品的持續供應。

將產品類型、材料化學、加工技術、產品形式、應用類別和最終用戶與市場接受度和技術要求聯繫起來的綜合細分分析

細緻的細分框架清楚地闡明了可生物分解醫用塑膠能夠立即發揮價值的領域以及仍存在技術挑戰的領域。基於產品類型的機會集中在手套和口罩等耗材上，這些耗材的一次性設計符合生物分解途徑；而包括檢測套組和X光片在內的診斷設備則需要仔細評估其無菌性和材料透明度；牽開器和手術刀等外科器械對機械可靠性和耐滅菌性提出了更高的要求；透析設備和人工呼吸器等治療設備則對性能和耐用性提出了複雜性能的要求。

區域管理體制、採購優先事項和製造地將如何影響美洲、歐洲、中東和非洲以及亞太地區的採用和商業化路徑

受管理體制、供應鏈佈局和醫療採購慣例等因素驅動的區域趨勢，將對可生物分解醫用塑膠的普及路徑產生重大影響。在美洲，採購機構和大型醫療系統正日益將環境標準納入競標流程，而北美製造業也迅速回應了對具有韌性的近岸供應鏈網路的需求。這種環境有利於那些兼具檢驗的臨床性能、透明的永續性和本土生產能力的供應商。

為什麼成熟的聚合物製造商、靈活的契約製造、醫療設備原始設備製造商和學術研究人員的匯聚將決定可生物分解醫用塑膠商業化的最終贏家？

生物分解醫用塑膠領域的競爭格局呈現出多方面的特徵：一方面，成熟的聚合物供應商正拓展醫用級配方業務；另一方面，醫療設備製造商正積極融入永續設計理念；契約製造製造商正努力建構檢驗能力；此外，一些專注於創新生物分解化學技術的專業Start-Ups也在不斷開拓創新。現有材料供應商利用其複合技術和全球分銷網路，提供符合可萃取性和可浸出性要求的醫用級產品。同時，醫療設備製造商（OEM）也擴大從初始設計階段就納入永續性標準，以確保產品與臨床工作流程和滅菌製程的兼容性。

產業領導者可立即實施切實有效的高影響力策略，以加速檢驗、確保供應鏈的韌性，並在不影響臨床表現的前提下整合生物分解性。

產業領導者應優先考慮切實可行的策略，將技術潛力轉化為廣泛的臨床應用。首先，應在產品開發生命週期的早期階段就整合材料鑑定，在進行機械和功能測試的同時，同步進行生物相容性、滅菌相容性和可萃取物/可浸出物測試。早期協調一致的檢驗能夠減少監管申報過程中出現意外問題，並縮短從原型到臨床評估的時間。

採用混合方法，結合關鍵相關人員訪談、實驗室檢驗、生命週期評估和供應鏈圖譜分析，確保獲得可靠且可操作的洞見。

本執行摘要的研究整合了初步訪談、實驗室檢驗研究和二手文獻，旨在對可生物分解醫用塑膠進行嚴謹、多角度的分析。初步研究包括對材料科學家、醫療設備工程師、採購經理和滅菌專家進行結構化訪談，以了解實際操作和實施障礙。實驗室檢驗包括機械性能測試、滅菌週期評估以及可萃取物/可浸出物篩檢，以評估材料在典型應用中的適用性。

技術準備、供應鏈韌性和協作檢驗途徑的平衡整合將決定可生物分解醫用塑膠從試點階段走向標準臨床實踐的路徑。

生物分解醫用塑膠在技術上可行，在策略上也具有重要意義，它既能減少醫療保健產業對環境的影響，又能保障病人安全和醫療設備的功能。向生物分解替代品的過渡在不同產品類型中進展速度各異：大消費量耗材和包裝材料可能率先採用，而植入和高性能手術器械則需要更廣泛的檢驗和更長的整合週期。這項進展取決於材料供應商、製造商、臨床醫生和監管機構能否攜手合作，就安全性、滅菌和生命週期結果達成共識。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 基於聚乳酸（PLA）的外科植入和縫線的監管核准趨勢正在加速發展。
  • 複合添加劑的創新可提高醫用聚合物的生物分解速率和機械強度
  • 3D列印生物可分解支架在組織工程和再生醫學的應用日益廣泛
  • 開發含有奈米材料的抗菌生物分解性塑膠，以降低感染風險
  • 利用可生物分解的生物聚酯，拓展一次性醫療設備的環保包裝解決方案
  • 生質塑膠生產商與醫療保健機構建立策略夥伴關係，拓展永續供應鏈
  • 基於PHA的藥物遞送系統的臨床評估表明，患者療效有所改善。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的可生物分解醫用塑膠市場

  • 消耗品
    • 手套
    • 面具
  • 診斷設備
    • 檢測套組
    • X光片
  • 手術器械
    • 牽開器
    • 女性
  • 治療設備
    • 透析設備
    • 人工呼吸器

9. 依材料類型分類的可生物分解醫用塑膠市場

  • Polybutylene Adipate Terephthalate
  • 聚己內酯
  • 聚乳酸
  • 澱粉基複合樹脂

第10章：按加工技術分類的可生物分解醫用塑膠市場

  • 3D列印
  • 吹塑成型
  • 擠壓
  • 射出成型

第11章：按產品類型分類的可生物分解醫用塑膠市場

  • 板條箱和貨櫃
  • 模製零件
  • 片材和薄膜

第12章：按應用分類的可生物分解醫用塑膠市場

  • 藥物輸送系統
    • 微球載體
    • 奈米顆粒載體
  • 醫院設施
    • 手術器械
    • 托盤和盆
  • 植入
    • 永久植入
    • 暫時植入
  • 包裝
    • 泡殼包裝
    • 注射器包裝

第13章 依最終用戶分類的可生物分解醫用塑膠市場

  • 診斷中心
    • 血液檢測中心
    • 診斷影像中心
  • 醫療設施
    • 診所
    • 醫院
  • 製藥公司
  • 大學和研究機構

第14章 各地區可生物分解醫用塑膠市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 生物分解醫用塑膠市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：各國可生物分解醫用塑膠市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Advanced & Functional Technologies For Biocomposites SL
    • Amcor PLC
    • Arkema Group
    • Ashland Inc.
    • Avient Corporation
    • BASF SE
    • Biome Technologies plc
    • Cardia Bioplastic by SECOS Group Limited
    • Celanese Corporation
    • Corbion NV
    • Danimer Scientific, Inc.
    • Eastman Chemical Company
    • Evonik Industries AG
    • Green Dot Bioplastics Inc
    • Koninklijke DSM NV
    • NatureWorks LLC by Cargill Incorporated
    • Neste Oyj
    • Novamont SpA by Versalis
    • Sabic
    • Solvay SA
    • Teijin Limited
    • TEYSHA TECHNOLOGIES LIMITED
    • Toray Industries, Inc.
    • Trinseo PLC
Product Code: MRR-1A1A064C05E6

The Biodegradable Medical Plastics Market is projected to grow by USD 9.35 billion at a CAGR of 7.90% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.09 billion
Estimated Year [2025] USD 5.46 billion
Forecast Year [2032] USD 9.35 billion
CAGR (%) 7.90%

Framing the convergence of clinical performance and sustainability as biodegradable medical plastics move from innovation labs into healthcare systems worldwide

The medical sector stands at a pivotal juncture where environmental stewardship and clinical performance must coexist. Biodegradable medical plastics have emerged as a pragmatic response to escalating concerns about single-use waste, end-of-life disposal challenges, and the carbon footprint associated with polymer-based medical devices. Advances in polymer chemistry, additive and subtractive manufacturing, and sterilization-compatible formulations now allow designers and manufacturers to reimagine disposables and durable components without compromising patient safety or regulatory compliance.

Transitioning from legacy petrochemical-derived materials to biodegradable alternatives demands a deep appreciation of material science, device functionality, and the clinical use environment. Clinicians and procurement teams increasingly require evidence that biodegradable solutions meet established biocompatibility, sterilization resilience, and mechanical performance standards. At the same time, environmental managers and sustainability officers prioritize materials that facilitate composting, enzymatic degradation, or safe incineration with lower toxic emissions. This intersection of clinical requirements and sustainability imperatives defines the current strategic challenge for manufacturers, suppliers, and health systems.

Consequently, stakeholders must assess new candidate materials alongside manufacturing processes such as extrusion and injection molding, as well as emerging techniques like 3D printing that enable part consolidation and function-specific architectures. Adoption pathways are shaped by clinical validation, regulatory acceptance, supply chain reliability, and lifecycle management practices. The remainder of this executive summary synthesizes these dynamics, highlights transformative shifts, and provides actionable guidance for advancing biodegradable medical plastics from promising innovation to institutionalized standard practice.

How material diversification, hybrid manufacturing, and evolving regulatory procurement frameworks are jointly reshaping the future adoption trajectory of biodegradable medical plastics

The landscape for biodegradable medical plastics is being reshaped by a series of interlocking transformative shifts that reconfigure supply chains, material priorities, and manufacturing paradigms. First, materials diversification drives capability; alternatives such as polylactic acid and polycaprolactone are no longer niche curiosities but viable candidates for a wider array of medical applications due to improved formulations and additive packages that enhance sterilization tolerance and mechanical strength. Alongside these, starch blends and novel copolymers offer cost-effective pathways for single-use consumables where rapid biodegradation is acceptable.

Second, processing technology is evolving from traditional high-volume molding toward a hybrid model that leverages both injection molding for standardized parts and 3D printing for patient-specific and low-volume devices. As 3D printing matures, it enables geometries and internal architectures that reduce raw material use, improve device function, and allow for rapid design iteration-factors that accelerate clinical validation cycles and reduce time-to-clinic for novel biodegradable devices. Concurrently, advances in blow molding and extrusion expand the range of form factors available for packaging and film applications, enabling biodegradable formulations to enter sterile barrier applications and flexible packaging systems.

Third, regulatory and procurement ecosystems are adapting. Regulatory authorities have increased scrutiny of material biocompatibility, extractables and leachables, and sterilization validation for biodegradable polymers, prompting manufacturers to invest in comprehensive preclinical and compatibility testing earlier in development. Procurement teams within hospitals and pharmaceutical companies are beginning to weigh the total lifecycle implications of product choices, leading to pilot programs that integrate waste-disposal costs and environmental criteria into purchasing decisions. Collectively, these shifts favor suppliers that offer validated performance, traceable supply chains, and transparent environmental credentials, thereby accelerating the integration of biodegradable plastics in clinical practice.

Assessing how the 2025 United States tariff adjustments are prompting supplier diversification, nearshoring, and vertical integration within medical polymer supply chains

Recent policy measures and tariff adjustments introduced by the United States in 2025 have exerted a discernible influence across international supply chains for medical polymers and ancillary components. Increased duties on certain imported resins and finished polymeric components have compelled manufacturers to reassess sourcing strategies, inventory policies, and supplier diversification plans. These trade policy changes have amplified attention on nearshoring and domestic capacity expansion as firms seek to protect continuity of supply for critical medical products.

Manufacturers responding to tariff-induced cost pressures are prioritizing supplier consolidation with partners who demonstrate consistent quality, traceable raw material provenance, and the ability to scale. For some, this has meant negotiating longer-term procurement agreements to stabilize input costs and secure capacity allocations. Others have accelerated qualification of alternative biodegradable resins produced outside the affected tariff categories, while maintaining rigorous biocompatibility and sterilization validation to preserve clinical acceptability.

The cumulative tariff environment has also catalyzed investment in vertical integration for a subset of producers that view control over polymer compounding and formulation as a strategic buffer against external price fluctuations. In parallel, contract manufacturers and toll processors with domestic capabilities have seen elevated interest from original equipment manufacturers seeking to mitigate cross-border risks. Healthcare systems and procurement offices are reacting by revisiting supply contracts and piloting vendor diversification to ensure resilience.

It is important to note that the tariff-driven reconfiguration is not uniform across product types and geographies. Components that require specialized compounding or tight regulatory pedigree-such as implantable device components-remain sensitive to supplier continuity, while higher-volume consumables can more readily be requalified across multiple vendors. The net effect is a supply chain that is more regionally focused, where trade policy imperatives influence decisions about where to locate production, which suppliers to partner with, and how to structure inventory strategies to preserve clinical continuity and cost-effectiveness.

Comprehensive segmentation analysis linking product types, material chemistries, processing technologies, product forms, application categories, and end users to adoption potential and technical requirements

A nuanced segmentation framework clarifies where biodegradable medical plastics can deliver immediate value and where technical hurdles remain. Based on product type, opportunities concentrate in consumables such as gloves and masks where single-use anatomy aligns with biodegradation pathways, while diagnostic devices that include testing kits and X-ray sheets demand careful evaluation of sterility and material transparency. Surgical devices such as retractors and scalpels present a higher bar for mechanical reliability and sterilization withstand, and therapeutic equipment including dialysis machines and respirators raise complex performance and longevity considerations.

Material type distinctions shape design choices and downstream processing. Polylactic acid offers a balanced profile for molded parts and sheets, polycaprolactone excels where flexibility and controlled degradation are required, polybutylene adipate terephthalate provides toughness in thicker structures, and starch blends present cost-efficient options for non-critical packaging and disposable items. Processing technology further differentiates application suitability. 3D printing allows for patient-specific geometries and rapid prototyping, blow molding yields hollow packaging and containers, extrusion facilitates continuous sheets and films, and injection molding remains the workhorse for consistent, high-volume components.

Product forms influence end-use integration and sterilization strategy. Crates and containers demand robust, reusable designs with sterilization compatibility, molded parts must balance surface finish and tolerances for instrument housings, and sheets and films focus on barrier properties and sealability for sterile packaging. Application-driven segmentation highlights distinct regulatory and performance pathways. Drug delivery systems involving microsphere carriers and nanoparticulate carriers require rigorous biocompatibility and release profiling, hospital equipment spanning surgical instruments and trays and basins must endure repeated sterilization cycles, implants categorized as permanent or temporary impose divergent degradation and tissue interaction requirements, and packaging formats such as blister packs and syringe packaging prioritize barrier integrity and compatibility with aseptic filling.

Finally, end-user segmentation informs adoption velocity and purchase criteria. Diagnostic centers including blood testing centers and imaging centers emphasize diagnostic accuracy and device specificity, healthcare facilities ranging from clinics to hospitals prioritize cost, disposability, and waste-management implications, pharmaceutical companies require validated materials for primary packaging and combination products, and universities and research institutions drive early-stage validation and translational research that informs commercial uptake. Aligning material choice, processing technology, and product form to these end-user expectations is central to designing viable biodegradable medical plastic solutions that can move from pilot to standard practice.

How regional regulatory regimes, procurement priorities, and manufacturing footprints across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and commercialization pathways

Regional dynamics exert strong influence on adoption pathways for biodegradable medical plastics, driven by regulatory regimes, supply chain footprints, and healthcare procurement practices. In the Americas, procurement agencies and major health systems increasingly integrate environmental criteria into tender processes, and North American manufacturing capacity has been responsive to demands for resilient, nearshore supply chains. This environment favors suppliers that can combine validated clinical performance with transparent sustainability credentials and domestic production capabilities.

In Europe, Middle East & Africa, regulatory frameworks and national sustainability commitments create both incentives and procedural hurdles. European regulatory authorities maintain stringent material safety and lifecycle reporting expectations, prompting manufacturers to invest in comprehensive compliance dossiers and third-party verification. In parts of the Middle East and Africa, rapid infrastructure development and rising healthcare demand create opportunities to introduce biodegradable options in new facilities, although adoption timing depends on logistical and regulatory alignment.

The Asia-Pacific region displays a broad spectrum of trajectories, with several markets advancing manufacturing capabilities, material innovation, and clinical adoption simultaneously. Regional manufacturing hubs supply polymers and finished components to global supply chains, while localized innovation ecosystems and academic partnerships accelerate trialing of biodegradable formulations and processing methods. Across all regions, cross-border trade dynamics, intellectual property considerations, and harmonization of safety standards remain central to how rapidly biodegradable medical plastics transition from pilot projects to routine procurement choices.

Why a blend of established polymer producers, agile contract manufacturers, device OEMs, and academic innovators will determine who wins in biodegradable medical plastics commercialization

Competitive dynamics in the biodegradable medical plastics space reflect a mixture of established polymer suppliers expanding into medical-grade formulations, device manufacturers integrating sustainable design principles, contract manufacturers building validation capabilities, and specialized startups pioneering novel biodegradable chemistries. Established materials suppliers are leveraging their compounding expertise and global distribution networks to offer medical-grade variants that meet extractables and leachables expectations, while device OEMs are increasingly embedding sustainability criteria into early-stage design decisions to ensure compatibility with clinical workflows and sterilization regimes.

Contract manufacturing organizations and precision molding houses that can demonstrate validated processes, cleanroom capabilities, and sterilization partnerships hold a strategic advantage because they reduce barriers for device makers to trial biodegradable alternatives without major retooling. Simultaneously, smaller innovators and university spin-outs contribute disruptive potential by introducing unique polymer blends and functional additives that target specific clinical challenges such as controlled degradation profiles or enhanced tissue integration for temporary implants.

Partnerships and consortiums that link material suppliers, device manufacturers, testing laboratories, and clinical partners are becoming a practical route to de-risk new product introductions. These collaborations accelerate materials qualification, share preclinical evidence, and create pathways for multi-center evaluations that satisfy both regulatory and procurement stakeholders. The competitive landscape rewards entities that combine technical rigor with an ability to scale supply reliably while maintaining necessary documentation for regulatory submissions and hospital procurement approvals.

Practical, high-impact strategies that industry leaders can implement immediately to accelerate validation, secure resilient supply chains, and integrate biodegradability without compromising clinical performance

Industry leaders should prioritize a set of actionable strategies to convert technical promise into widespread clinical adoption. First, integrate material qualification early in the product development lifecycle, ensuring that biocompatibility, sterilization compatibility, and extractables and leachables studies run in parallel with mechanical and functional testing. Early and coordinated validation reduces downstream surprises during regulatory submission and shortens the time between prototype and clinical evaluation.

Second, diversify supply chains while investing in strategic supplier relationships that offer traceable raw material provenance and consistency in polymer compounding. Where tariffs or trade uncertainty are material considerations, evaluate nearshoring options and partnerships with toll processors to secure production continuity. Third, adopt hybrid manufacturing strategies that leverage injection molding for high-volume repeatable parts and 3D printing for patient-specific or complex geometries, thereby optimizing cost, performance, and customization potential.

Fourth, engage proactively with regulatory authorities and procurement stakeholders to align on acceptable validation pathways and environmental reporting requirements. Pilot programs with health systems and diagnostic centers can provide real-world performance data that shortens procurement approval cycles. Fifth, implement lifecycle and end-of-life planning early, including compatibility with existing sterilization and waste-management infrastructure, and communicate environmental benefits with evidence-based lifecycle assessments. Finally, cultivate cross-sector collaborations that bring together material scientists, clinicians, sterilization experts, and supply chain specialists to address the multidisciplinary challenges inherent in biodegradable medical plastics.

An integrated mixed-methods approach combining primary stakeholder interviews, laboratory validation, lifecycle assessments, and supply chain mapping to ensure robust and actionable insights

The research underpinning this executive summary synthesized primary interviews, laboratory validation studies, and secondary literature to create a rigorous, multidimensional view of biodegradable medical plastics. Primary research included structured interviews with materials scientists, device engineers, procurement leaders, and sterilization experts to capture operational realities and adoption barriers. Laboratory validation incorporated mechanical testing, sterilization cycle assessments, and extractables and leachables screening to evaluate material suitability across representative application classes.

Secondary sources comprised peer-reviewed publications, regulatory guidance documents, standards from recognized bodies, and publicly available technical dossiers that describe material behavior and clinical use cases. Supply chain mapping and trade-flow analysis informed the assessment of tariff impacts and regional manufacturing capabilities, while lifecycle assessment methodologies were applied to compare end-of-life trajectories and environmental implications of candidate polymers. Where applicable, case studies of pilot programs and early commercial deployments provided context about clinical acceptance and procurement decision criteria.

Triangulation of these data streams ensured that conclusions are grounded in both laboratory-based evidence and real-world operational insights. Quality control measures included cross-validation of interview themes against laboratory findings and regulatory expectations, and methodological transparency was maintained through clear documentation of data sources, sample sizes, and testing protocols. This mixed-methods approach supports robust, actionable recommendations tailored to diverse stakeholders across the value chain.

A balanced synthesis of technical readiness, supply chain resilience, and collaborative validation pathways that determines how biodegradable medical plastics move from pilots to standard clinical practice

Biodegradable medical plastics represent a technically viable and strategically important pathway for reducing the environmental footprint of healthcare while maintaining patient safety and device functionality. The transition to biodegradable alternatives will be uneven across product categories: high-volume consumables and packaging are poised for earlier adoption, while implants and high-performance surgical instruments require more extensive validation and longer integration timelines. Progress will hinge on coordinated efforts among material suppliers, manufacturers, clinicians, and regulators to align on safety, sterilization, and lifecycle outcomes.

Supply chain resilience, influenced by regional manufacturing capabilities and trade policies, will continue to shape where and how biodegradable solutions are produced and sourced. Equally important is the capacity of the industry to generate convincing clinical and environmental evidence that satisfies procurement teams and regulatory authorities. Those organizations that invest in early validation, flexible manufacturing strategies, and transparent lifecycle reporting will be best positioned to capture the operational and reputational benefits of sustainable materials.

Ultimately, the promise of biodegradable medical plastics depends less on a single breakthrough material and more on the integration of validated formulations, scalable processing methods, and aligned stakeholder incentives. By focusing on pragmatic pilots, rigorous testing, and strategic partnerships, the sector can convert innovation into measurable reductions in clinical plastic waste while safeguarding clinical outcomes and supply chain continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Regulatory approval trends for PLA-based surgical implants and sutures gaining momentum
  • 5.2. Innovations in compound additives to enhance biodegradation rates and mechanical strength of medical polymers
  • 5.3. Rising adoption of 3D printed biodegradable scaffolds for tissue engineering and regenerative medicine
  • 5.4. Development of antimicrobial biodegradable plastics infused with nanomaterials to reduce infection risks
  • 5.5. Expansion of eco-friendly packaging solutions for single-use medical devices using compostable biopolyesters
  • 5.6. Strategic partnerships between bioplastic producers and healthcare providers to scale sustainable supply chains
  • 5.7. Clinical evaluations of PHA-based drug delivery systems demonstrating improved patient outcomes

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biodegradable Medical Plastics Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Gloves
    • 8.1.2. Masks
  • 8.2. Diagnostic Devices
    • 8.2.1. Testing Kits
    • 8.2.2. X-ray Sheets
  • 8.3. Surgical Devices
    • 8.3.1. Retractors
    • 8.3.2. Scalpels
  • 8.4. Therapeutic Equipment
    • 8.4.1. Dialysis Machines
    • 8.4.2. Respirators

9. Biodegradable Medical Plastics Market, by Material Type

  • 9.1. Polybutylene Adipate Terephthalate
  • 9.2. Polycaprolactone
  • 9.3. Polylactic Acid
  • 9.4. Starch Blends

10. Biodegradable Medical Plastics Market, by Processing Technology

  • 10.1. 3D Printing
  • 10.2. Blow Molding
  • 10.3. Extrusion
  • 10.4. Injection Molding

11. Biodegradable Medical Plastics Market, by Product Forms

  • 11.1. Crates & Containers
  • 11.2. Molded Parts
  • 11.3. Sheets & Films

12. Biodegradable Medical Plastics Market, by Application

  • 12.1. Drug Delivery Systems
    • 12.1.1. Microsphere Carriers
    • 12.1.2. Nanoparticulate Carriers
  • 12.2. Hospital Equipment
    • 12.2.1. Surgical Instruments
    • 12.2.2. Trays and Basins
  • 12.3. Implants
    • 12.3.1. Permanent Implants
    • 12.3.2. Temporary Implants
  • 12.4. Packaging
    • 12.4.1. Blister Packs
    • 12.4.2. Syringe Packaging

13. Biodegradable Medical Plastics Market, by End User

  • 13.1. Diagnostic Centers
    • 13.1.1. Blood Testing Centers
    • 13.1.2. Imaging Centers
  • 13.2. Healthcare Facilities
    • 13.2.1. Clinics
    • 13.2.2. Hospitals
  • 13.3. Pharmaceutical Companies
  • 13.4. Universities and Research Institutions

14. Biodegradable Medical Plastics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Biodegradable Medical Plastics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Biodegradable Medical Plastics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Advanced & Functional Technologies For Biocomposites SL
    • 17.3.2. Amcor PLC
    • 17.3.3. Arkema Group
    • 17.3.4. Ashland Inc.
    • 17.3.5. Avient Corporation
    • 17.3.6. BASF SE
    • 17.3.7. Biome Technologies plc
    • 17.3.8. Cardia Bioplastic by SECOS Group Limited
    • 17.3.9. Celanese Corporation
    • 17.3.10. Corbion NV
    • 17.3.11. Danimer Scientific, Inc.
    • 17.3.12. Eastman Chemical Company
    • 17.3.13. Evonik Industries AG
    • 17.3.14. Green Dot Bioplastics Inc
    • 17.3.15. Koninklijke DSM N.V.
    • 17.3.16. NatureWorks LLC by Cargill Incorporated
    • 17.3.17. Neste Oyj
    • 17.3.18. Novamont S.p.A. by Versalis
    • 17.3.19. Sabic
    • 17.3.20. Solvay S.A.
    • 17.3.21. Teijin Limited
    • 17.3.22. TEYSHA TECHNOLOGIES LIMITED
    • 17.3.23. Toray Industries, Inc.
    • 17.3.24. Trinseo PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT FORMS, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT FORMS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. BIODEGRADABLE MEDICAL PLASTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. BIODEGRADABLE MEDICAL PLASTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIODEGRADABLE MEDICAL PLASTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GLOVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GLOVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GLOVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GLOVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GLOVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY GLOVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MASKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MASKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MASKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MASKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MASKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MASKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TESTING KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TESTING KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TESTING KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TESTING KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TESTING KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TESTING KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY X-RAY SHEETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY X-RAY SHEETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY X-RAY SHEETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY X-RAY SHEETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY X-RAY SHEETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY X-RAY SHEETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RETRACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RETRACTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RETRACTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RETRACTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RETRACTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RETRACTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SCALPELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SCALPELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SCALPELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SCALPELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SCALPELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SCALPELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIALYSIS MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIALYSIS MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIALYSIS MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIALYSIS MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIALYSIS MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIALYSIS MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RESPIRATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RESPIRATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RESPIRATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RESPIRATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RESPIRATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY RESPIRATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYCAPROLACTONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYCAPROLACTONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYCAPROLACTONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYCAPROLACTONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYLACTIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYLACTIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYLACTIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY POLYLACTIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY STARCH BLENDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY STARCH BLENDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY STARCH BLENDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY STARCH BLENDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY STARCH BLENDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY STARCH BLENDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY 3D PRINTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY 3D PRINTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY 3D PRINTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT FORMS, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT FORMS, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CRATES & CONTAINERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CRATES & CONTAINERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CRATES & CONTAINERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CRATES & CONTAINERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CRATES & CONTAINERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CRATES & CONTAINERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MOLDED PARTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MOLDED PARTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MOLDED PARTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MOLDED PARTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MOLDED PARTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MOLDED PARTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SHEETS & FILMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SHEETS & FILMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SHEETS & FILMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SHEETS & FILMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SHEETS & FILMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SHEETS & FILMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MICROSPHERE CARRIERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MICROSPHERE CARRIERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MICROSPHERE CARRIERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MICROSPHERE CARRIERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MICROSPHERE CARRIERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY MICROSPHERE CARRIERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY NANOPARTICULATE CARRIERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY NANOPARTICULATE CARRIERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY NANOPARTICULATE CARRIERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY NANOPARTICULATE CARRIERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY NANOPARTICULATE CARRIERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY NANOPARTICULATE CARRIERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITAL EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TRAYS AND BASINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TRAYS AND BASINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TRAYS AND BASINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TRAYS AND BASINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TRAYS AND BASINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TRAYS AND BASINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PERMANENT IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PERMANENT IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PERMANENT IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PERMANENT IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PERMANENT IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PERMANENT IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TEMPORARY IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TEMPORARY IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TEMPORARY IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TEMPORARY IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TEMPORARY IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY TEMPORARY IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLISTER PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SYRINGE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SYRINGE PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SYRINGE PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SYRINGE PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SYRINGE PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY SYRINGE PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOOD TESTING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOOD TESTING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOOD TESTING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOOD TESTING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOOD TESTING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY BLOOD TESTING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HEALTHCARE FACILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL BIODEGRADABLE MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL BIODEGRADABLE MEDICAL